Kristina N. Sigmon

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.

E. Magnus Ohman, Robert M. Califf, Eric J. Topol et al. · Circulation · 1990 · 418 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +10

Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction

E. Magnus Ohman, Neal S. Kleiman, Gerald M. Gacioch et al. · Circulation · 1997 · 381 citations

Medicine, Pharmacology, Pharmacotherapy +17

Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

James E. Tcheng, Robert A. Harrington, Kandice Kottke‐Marchant et al. · Circulation · 1995 · 281 citations

Medicine, Cardiology, Pharmacology +17

Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary Intervention

Frank V. Aguirre, Eric J. Topol, James J. Ferguson et al. · Circulation · 1995 · 242 citations

Medicine, Cardiology, Pharmacotherapy +17